Prostate Cancer
Bone metastases treated with radiopharmaceuticals - Abstract
February 7, 2014
Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer - Abstract
February 7, 2014
Luteinizing hormone-releasing hormone antagonists for urinary obstruction in prostate cancer - Abstract
February 7, 2014
Change in prostate volume during extreme hypo-fractionation analysed with MRI - Abstract
February 7, 2014
A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients - Abstract
February 7, 2014
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium - Abstract
February 7, 2014
Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions - Abstract
February 7, 2014
The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients - Abstract
February 7, 2014
Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy - Abstract
February 6, 2014
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer - Abstract
February 6, 2014
Vitamin D and prostate cancer survival in veterans - Abstract
February 6, 2014
Sensorimotor polyneuropathy and foot-drop as result of a prostate cancer paraneoplastic syndrome - Abstract
February 6, 2014
(11)C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy - Abstract
February 6, 2014